THE NEW DIAGNOSTIC FEATURES OF CD138 (SYNDECAN-1) IN MULTIPLE MYELOMA

by A. F. Karamysheva
Published 2015-12-01

The importance of preexisting drug resistance due to overexpression of P-glycoprotein for the formation of resistance to bortezomib

by L. A. Laletina, N. I. Moiseeva, A. F. Karamysheva
Published 2020-03-01

Analysis of VEGF-A/VEGFR1/VEGFR2 gene expression in patients with myelodysplastic syndrome

by N N Kalitin, G A Dudina, S V Semochkin, A F Karamysheva
Published 2017-07-01

Gene expression of vascular endothelial growth factors and their receptors in different variants of the course of multiple myeloma

by A K Golenkov, I V Buravtsova, G A Dudina, T D Lutskaia, T A Mitina, E V Kataeva, A F Karamysheva, E S Kakpakova, Iu A Sablina, A A Stavrovskaia
Published 2013-07-01

THE EFFECT OF MULTIDRUG RESISTANCE GENE EXPRESSION ON THE CLINICAL COURSE OF MULTIPLE MYELOMA

by Yu. B. Chernykh, A. K. Golenkov, S. S. Shushanov, T. A. Kravtsova, E. Yu. Rybalkina, A. F. Karamysheva, T. A. Mitina, E. V. Trifonova, E. V. Kataeva, L. L. Vysotskaya, A. A. Stavrovskaya
Published 2017-01-01